¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Becker type tardive muscular dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • muscular process
    ±ÙÀ°µ¹±â
  • muscular reflex
    ±Ù(À°)¹Ý»ç
  • muscular stiffness
    ±Ù(À°)°æÁ÷, ±Ù(À°)°­Á÷
  • muscular strabismus
    ±ÙÀ°¼º»ç½Ã
  • muscular strain
    1. ±Ù(À°)°úµµ±äÀå 2. ±ÙÀ°¿°ÁÂ
  • muscular tissue
    ±Ù(À°)Á¶Á÷
  • muscular triangle
    ±Ù(À°)»ï°¢
  • neurogenic muscular atrophy
    ½Å°æ¼º±Ù(À°)À§Ãà
  • progressive spinal muscular atrophy
    ÁøÇàô¼ö¼º±Ù(À°)À§ÃàÁõ
  • spinal muscular atrophy
    ô¼ö±Ù(À°)À§ÃàÁõ
  • asthenic type
    ¹«·ÂüÇü
  • blood type
    Ç÷¾×Çü
  • Borrmann type
    º¸¸£¸¸Çü
  • Cowdry type A inclusion bodies
    Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
  • Cowdry type B inclusion bodies
    Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • muscular hypotonia
    ±ÙÀ°±äÀåÀúÇÏ
  • idiopathic muscular spasm
    Ư¹ß±ÙÀ°¿¬Ãà
  • muscular neurotization
    ±ÙÀ°³»½Å°æÀç»ý
  • muscular paralysis
    ±ÙÀ°¸¶ºñ
  • muscular process
    ±ÙÀ°µ¹±â
  • muscular reflex
    (¢¡stretch reflex) »¸Ä§¹Ý»ç, ½ÅÀå¹Ý»ç
  • muscular stiffness
    ±ÙÀ°°æÁ÷, ±ÙÀ°°­Á÷
  • muscular strabismus
    ±ÙÀ°»ç½Ã
  • muscular strain
    ±ÙÀ°°úµµ±äÀå
  • muscular tissue
    ±ÙÀ°Á¶Á÷
  • muscular ventricular septum
    ±ÙÀ°½É½Ç»çÀ̸·, ±ÙÀ°½É½ÇÁß°Ý
  • abortive type
    ºÎÀüÇü
  • anovulatory type
    ¹«¹è¶õÇü
  • asthenic type
    ¹«·ÂüÇü
  • athletic type
    °ÇÀåÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • C type particle
    CÇüÀÔÀÚ
  • C-type particle
    CÇü ÀÔÀÚ (·¹Æ®·Î¹ÙÀÌ·¯½ºÀÇ)
  • C-type virus particle
    CÇü ¹ÙÀÌ·¯½ºÀÔÀÚ.
  • Charcot-Marie type
    »þ¸£ÄÚ-¸¶¸®Çü.
  • Duchenne-Landouzy type
    µÚ½Ã¿£´À-¶õµÎ¿ìÁöÇü.
  • Gougerot-Ruiter type vasculitis
    ±¸Á¦·Î ·çÀÌÅÍ Çü Ç÷°ü¿°
  • L-type chnnels
    L-Çü Åë·Î(÷×ÖØ)
  • Lafora body type of myoclonus
    ¶óÆ÷¶ó üÇü ¸¶ÀÌ¿ÀŬ·Î´©½º.
  • Lutheran s type
    ·çÅ×¶õÇü.
  • Mobitz type I SA block
    ¸ðºñÃ÷ ¥°Çü µ¿¹æÂ÷´Ü.
  • Mobitz type II AV block
    ¸ðºñÃ÷ ¥±Çü ¹æ½ÇÂ÷´Ü.
  • Mobitz type II SA block
    ¸ðºñÃ÷ ¥±Çü µ¿¹æÂ÷´Ü.
  • Ogawa type
    ¿À°¡¿ÍÇü
  • RF coil type
    °íÁÖÆÄ ÄÚÀÏ À¯Çü
  • T-type channel
    T-Çü Åë·Î
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cone-rod dystrophy
    Ãßü°£Ã¼ÀÌ¿µ¾ç(Áõ)
  • corneal dystrophy
    °¢¸·ÀÌ¿µ¾ç(Áõ)
  • crystalline corneal dystrophy
    °áÁ¤°¢¸·ÀÌ¿µ¾ç(Áõ)
  • deep corneal dystrophy
    ½ÉÃþ°¢¸·ÀÌ¿µ¾ç(Áõ)
  • dermo-chondro-corneal dystrophy
    ÇǺΠ¿¬°ñ °¢¸· À§ÃàÁõ
  • dominant cystoid macular dystrophy
    ¿ì¼º³¶Æ÷Ȳ¹ÝÀÌ¿µ¾ç(Áõ)
  • dystrophy
    ÀÌ¿µ¾ç
  • dystrophy
    ÀÌ¿µ¾çÁõ(ì¶ç½å×ñø), ¿µ¾ç½ÇÁ¶(ç½å×ã÷ðà), ±â´ÉÀå¾Ö(ѦÒöî¡ ),
  • dystrophy
    ¿µ¾çÀå¾Ö
  • dystrophy (intestinal lipodystrophy)
    ¿µ¾çÀå¾Ö(âÀÚÁö¹æ¿µ¾çÀå¾Ö)
  • dystrophy myotonia
    ±Ù °æÁ÷¼º ÀÌ¿µ¾çÁõ
  • endothelial corneal dystrophy
    °¢¸·³»ÇÇÀÌ¿µ¾ç(Áõ)
  • fingerprint dystrophy
    Áö¹®»ó(°¢¸·)ÀÌ¿µ¾ç(Áõ)
  • fleck corneal dystrophy
    ¹ÝÁ¡°¢¸·ÀÌ¿µ¾çÁõ
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ¿µ¾çÁõ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Irregular type
    ºÒ±ÔÄ¢Çü
    [¿¾ ¿ë¾î] ºÒ±ÔĢġ¹Ð°áÇÕÁ¶Á÷
  • Calcified hypertrophic type
    ¼®È¸È­ºñ´ëÇü
    [¿¾ ¿ë¾î] ¼®È¸È­ºñ´ëÇü
  • Fibrous type of lymphatic vessel
    ¼¶À¯Çü¸²ÇÁ°ü
    [¿¾ ¿ë¾î] ¼¶À¯ÇüÀӯİü
  • Type II hair cell
    ¿øÁÖÅм¼Æ÷
    [¿¾ ¿ë¾î] ÀüÆÄ¿¬Á¢¼¼Æ÷
  • Type A spermatogonium
    À¸¶äÁ¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] AÁ¤Á¶¼¼Æ÷
  • Type I hair cell
    Á¶·Õ¹ÚÅм¼Æ÷
    [¿¾ ¿ë¾î] ¹è»ó¿¬Á¢¼¼Æ÷
  • Elastic type of artery
    ź·ÂÇüµ¿¸Æ
    [¿¾ ¿ë¾î] ź·ÂÇüµ¿¸Æ
  • Glomus type of arteriovenous anastomosis
    Å丮Çüµ¿Á¤¸Æ¿¬°á
    [¿¾ ¿ë¾î] ±¸Çüµ¿Á¤¸Æ¹®ÇÕ
  • Mixed type of artery
    È¥ÇÕÇüµ¿¸Æ
    [¿¾ ¿ë¾î] È¥ÇÕÇüµ¿¸Æ
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Pneumocyte type II
    °ú¸³ÇãÆÄ²Ê¸®¼¼Æ÷
    [¿¾ ¿ë¾î] ´ëÆóÆ÷¼¼Æ÷
  • Golgi type I neuron
    ±äÃà»è½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ÀåÃà»è´Ù±Ø½Å°æ¿ø
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷(Á¦2Çü»ç±¸¼¼Æ÷)
  • Hypertrophic type
    ºñ´ëÇü
    [¿¾ ¿ë¾î] ºñ´ëÇü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
CASMD congenital atonic sclerotic muscular dystrophy
COD-MD cerebro-ocular dysplasia-muscular dystrophy [syndrome]
CXMD canine X-linked muscular dystrophy
DMD disease-modifying drug; Doctor of Dental Medicine; Duchenne muscular dystrophy; dystonia musculorum ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FCMD Fukuyama congenital muscular dystrophy
LGMD Limb girdle muscular dystrophy
MD MUSCULAR DYSTROPHY
MMD Myotonic muscular dystrophy
MyD Myotonic muscular dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscular hernia
    ±Ù Çã´Ï¾Æ
    ±ÙÀÌ ¼Õ»óµÈ ±Ù¸·ÀÇ ÀçÁø Æ´¿¡¼­ Å»ÃâÇØ ÇÇÇÏ¿¡ ´ê´Â »óŸ¦ ¸»ÇÑ´Ù. ±ÙÀ» ½ÅÀüÇÑ »óÅ¿¡¼­´Â ¿ëÀÌÇÏ°Ô È¯³³ÇÒ ¼ö ÀÖ°í °¡º­¿î °ÍÀº ¹æÄ¡Çصµ ÁöÀåÀº ¾ø´Âµ¥ °íµµÀÇ °ÍÀº ±Ù¸·ÀÇ ÀçÁø Æ´À» º¸ÇÕÇÏ°í Æó¼âÇÑ´Ù.
  • muscular hypertrophy
    ±ÙÀ° ºñ´ëÁõ, ±ÙÀ° ºñ´ë, ±Ù ºñ´ë
    ±Ù ºñ´ë´Â ±Ù ¼¶À¯ÀÇ Å©±âÀÇ Áõ°¡¸¦ ÀǹÌÇÑ´Ù. Áö¹æ ħÀ±, Á¾¾ç, ¿°Áõ¼º º´º¯¿¡ µû¸¥ ¿Ü°ß»ó ºñ´ë¸¦ °¡¼º ºñ´ë¶ó°í ÇÏ°í »ç½Ç»óÀÇ ºñ´ë¿Í ±¸º°ÇÑ´Ù. °Ç°­ÇÑ ±ÙÀ°µµ Àå±â¿¡ °ÉÄ£ °úÀ× ÀÛ¾÷À¸·Î ÀÎÇØ ºñ´ë¸¦ ÀÏÀ¸Å²´Ù. ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõÀÇ °æ¿ì ºñÀå±ÙÀÇ ºñ´ë°¡ Á¾Á¾ ù Áõ»óÀÌ µÈ´Ù. ¼±Ãµ¼º ±Ù ±äÀåÁõ¿¡¼­µµ ±Ù ºñ´ë¸¦ º¸°Ô µÈ´Ù. ±Ù ºñ´ë¿¡´Â ³²¼º È£¸£¸ó µîÀÇ ³»ºÐºñ ÀÎÀÚµµ Áß¿äÇÑ ¿ªÇÒÀ» Áö´Ñ´Ù.
  • muscular paralysis
    ±Ù ¸¶ºñ
  • muscular reflex
    ±Ù ¹Ý»ç, ±ÙÀ° ¹Ý»ç
    ±ÙÀ° ½ÅÀüÀ¸·Î ÀϾ´Â ¹Ý»ç ¿îµ¿.
  • muscular rheumatism
    ±ÙÀ° ·ù¸¶Æ¼Áò
    ÇǺΠ½Å°æÀÇ ±Ù¸· °üÅëºÎ ºÎ±ÙÀÇ ¿°ÁõÀ¸·Î ÀÌ ºÎÀ§ÀÇ ±ÙÀÇ ±äÀå, ¾ÐÅëÀÌ ÀÖÀ¸¸ç °íµµÀÎ °æ¿ì¿¡´Â ±× ÇǽŰæÀÇ ºÐÆ÷ ¿µ¿ª¿¡ »ó´çÇÑ ¸¶ºñ³ª Áö°¢ °ú¹Î, ¶Ç´Â Áö°¢ µÐ¸¶°¡ ÀÎÁ¤µÈ´Ù. ÀÚÁÖ ¹ß»ýÇÏ´Â ºÎÀ§·Î¼­´Â °ß°©ºÎ¿¡¼­ÀÇ ±ØÇϽŰæ, µÐºÎ¿¡¼­ÀÇ »óÀüÇǽŰæÀÇ ±Ù¸· °üÅëºÎ¸¦ µé ¼ö ÀÖ´Ù. º´ÀÎÀ¸·Î¼­´Â ·ù¸¶Æ¼Áò¼º ¿°ÁõÀ̶ó´Â ¼³µµ Àִµ¥ ÇöÀç·Î¼­´Â È®½ÇÇÏ°Ô ¹àÇôÁø °ÍÀÌ ¾ø´Ù. Ä¡·á·Î¼­´Â ¼Ò¿°ÁøÅëÁ¦ÀÇ Åõ¿©³ª ¿Â¿­, ±× ¹ÛÀÇ ÀÌÇÐÀû ¿ä¹ýÀÌ ÀÌ·ç¾îÁö°í ÀÖ´Ù.
  • muscular ring
    ±Ùȯ
  • muscular splinting
    ±ÙÀ° º¸Á¤
  • muscular strabismus
    ±Ù¼º »ç½Ã
  • muscular system
    ±ÙÀ° °èÅë, ±Ù°è
  • muscular tremor
    ±Ù Áøµ¿
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • tonic muscular hyperactivity
    ±äÀ强 ±ÙÀ° °úȰ¼º
  • abortive type
    ºÎÀüÇü
  • adenoid type
    ¼±¾ç
  • Bamberger's type
    ¸¸¼º ´Ù¹ß¼º À帷¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
reflex sympathetic dystrophy A syndrome of pain and tenderness, usually to a hand or foot, associated with vasomotor instability, skin changes and rapid development of bony demineralisation (osteoporosis). Frequently will follow a localised trauma, stroke or peripheral nerve injury.
(27 Sep 1997)
reflex sympathetic dystrophy syndrome <syndrome> A condition that features a group of typical symptoms, including pain (often burning type), tenderness, and swelling of an extremity associated with varying degrees of sweating, warmth and/or coolness, flushing, discoloration, and shiny skin.
(12 Dec 1998)
vitreo-tapetoretinal dystrophy Autosomal recessive bilateral peripheral and central retinoschisis with pigmentary degeneration of the retina, chorioretinal atrophy, vitreous degeneration, and night blindness.
Synonym: Favre's dystrophy.
(05 Mar 2000)
Meesman dystrophy Epithelial dystrophy characterised by progressive cysts and opacities of the corneal epithelium, with onset in infancy.
Inheritance: autosomal dominant with incomplete penetrance.
Synonym: Meesman dystrophy.
(22 Sep 2002)
vulvar dystrophy A spectrum of vulvar eruptions consisting of white atrophic papules, including lichen sclerosus et atrophicus, squamous cell hyperplasia (hypertrophic dystrophy), or a combination of these (mixed dystrophy).
See: lichen sclerosus et atrophicus.
(05 Mar 2000)
reticular dystrophy of cornea <ophthalmology> Bilateral, progressive, superficial degeneration of the corneal epithelium and adjacent Bowman's membrane.
(05 Mar 2000)
Groenouw's corneal dystrophy A granular type of corneal dystrophy, with autosomal dominant inheritance, a macular type of corneal dystrophy, with autosomal recessive inheritance.
(05 Mar 2000)
ring-like corneal dystrophy Thread-like opacities of the anterior corneal stroma, with acute, painful onset followed by decreased vision; autosomal dominant inheritance.
(05 Mar 2000)
gutter dystrophy of cornea A marginal furrow usually inferiorly about 1 mm from the limbus; and sometimes bilateral.
Synonym: keratoleptynsis.
(05 Mar 2000)
microcystic epithelial dystrophy Bilateral, symmetrical intraepithelial cysts in the central area of the cornea of healthy women, without hereditary predisposition.
(05 Mar 2000)
mucopolysaccharide keratin dystrophy A histologic finding seen in the surface epithelium of oral inflammatory fibrous hyperplasia, consisting of homogeneous eosinophilic pools of material in the superficial spinous layer.
(05 Mar 2000)
cone dystrophy A retinal abnormality in which colour perception is severely deficient and typical changes occur in electroretinogram.
See: achromatopsia.
Synonym: cone degeneration.
(05 Mar 2000)
corneal dystrophy Central corneal opacification, usually bilateral, symmetrical, and often autosomal recessive, involving predominantly epithelial, stromal, or endothelial layers, often in a typical pattern.
(05 Mar 2000)
myotonic dystrophy <neurology> An inherited human neuromuscular disease classed as an autosomal dominant disease in which there is progressive muscle weakening and wasting.
A triplet repeat syndromes (like fragile X syndrome), this most common adult form of muscular dystrophy is caused by expansion of the unstable trinucleotide repeat CTG in the 3' untranslated region on chromosome 19q13 (cAMP-dependent muscle protein kinase gene).
Anticipation has been associated with further expansion of the repeat upon transmission to subsequent generations (the inheritance pattern is autosomal dominant), although contraction has been noted to occur as well. Especially severe neonatal cases have been born to affected mothers preferentially, suggesting a role for genomic imprinting as well.
The classic physical signs include atrophy of facial muscles, cataracts, and delayed muscle relaxation. Detection of the expanded trinucleotide repeat is accomplished by PCR or Southern blot and expansion appears to correlate with decreased transcription of the protein kinase gene.
Inheritance: autosomal dominant.
(29 Dec 1997)
craniocarpotarsal dystrophy Congenital association of skeletal defects (ulnar deviation of hands with camptodactyly, talipes equinovarus, and frontal bone defects) and characteristic facies (protrusion of lips as in whistling, sunken eyes with hypertelorism, and small nose); autosomal dominant inheritance.
Synonym: craniocarpotarsal dysplasia, Freeman-Sheldon syndrome, whistling face syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á